The fatty acid analysis in Pliek U and its bioinformatic studies had been carried out and reported. Herein, fatty acids were analyzed by gas chromatography-mass spectrometry (GC-MS), meanwhile their potential effect, based on its interaction on epidermal fatty acid binding protein (E-FABP), was studied by bioinformatics approach with reverse docking technique using palmitic acid as a control compound. For the stated purpose, two Pliek U extracts were prepared, namely ethanolic Pliek U extract (EPUE), and ethanolic of residue hexane of Pliek U extract (ERHPUE). The GC-MS results showed that lauric, myristic, palmitic, and oleic acids were predominant, followed by stearic, capric, linoleic, and caprylic acids. Reverse docking results showed that linoleic acid had the lowest binding affinity (-5.9 kcal/mol) and was strongly bound to E-FABP on the same side of amino acid GLN A98, ARG A81, TYR A22, and LYS A61. These findings indicated that linoleic acid has a potential utility as a drug candidate for atopic dermatitis treatment.
INTRODUCTION
The fatty acid is one of three mayor lipids in stratum corneum (Elias 2014; Jungersted et al. 2008; McCusker & Grant-Kels 2010) . Along with filaggrin, it becomes a major component in the lipid-protein matrix, which functions as a protective barrier on the skin (Sandilands et al. 2009; van Smeden et al. 2014 )loss-of-function mutations in FLG, the human gene encoding profilaggrin and filaggrin, have been identified as the cause of the common skin condition ichthyosis vulgaris (which is characterised by dry, scaly skin. A deficiency of fatty acid in stratum corneum is one of the causes of skin barrier disfunction, especially in atopic dermatitis disease. It can be caused by a fatty acid biosynthesis problem or mechanical damage due to a secondary disease such as pruritus (Thyssen & Kezic 2014) .
A medical treatment to repair the skin barrier disfunction caused by fatty acid deficiency is fatty acid cream therapy. The cream is used as a pharmaceutical media to attach a fatty acid content to external disease target. Due to their hydrophobicity, fatty acids are virtually insoluble in body fluid. Their movement between cell membranes requires a special mechanism that involves a transport protein. The epidermal fatty acid binding protein (E-FABP), predominantly produced in the epidermis, is reported to have a role in transport protein process (Ogawa et al. 2011; Owada et al. 2002) .
The fatty acid source to supply a drug requirement can be obtained from animal or plant (Jumat et al. 2010) , one of them is coconut. In Indonesia, coconut is one of the prominent agricultural commodities. In Bireuen District, Aceh Province, coconut meat is traditionally processed through natural fermentation to produce fermentedcoconut oil called Pliek U Oil. This process also produces a secondary product called Pliek U (fermented coconut meat) (Vaughn 2018). Pliek U is commonly used as an ingredient in the traditional culinary by the local people (Arpi 2013) , whereas the fatty acid content in this coconut product has a potential to be used as a pharmacy resource.
It is important to know the detail fatty acid content in coconut product when it is used to medical purposes. Every fatty acid gives different drug activities depending on the fit between the fatty acid structure and the protein receptor. In another hand, the geographic factor always influences the fatty acid content in coconut cultivated from different locations, varieties of crop (Laureles et al. 2002) , times of harvesting (Carandang 2008 ) and age of nuts (Balleza & Sierra 1976) . Gas chromatography analysis has been reported as a good method to analyze fatty acid of coconut meat product. Non-volatile property of fatty acid was resolved with derivatization of its extract to be volatile compounds (Azeez 2007; Jumat et al. 2014; Laureles et al. 2002) .
A drug activity of fatty acid in case of atopic dermatitis treatment is assessed firstly with E-FABP protein. This protein transports the fatty acid to drug target (filaggrin) in stratum corneum. So that, the best fit of fatty acid content with E-FABP will affect the drug activity of fatty acid to treat atopic dermatitis. To study the drug activity, a virtual screening method using molecular docking has been proposed. This computational method gives the way to minimize several bio laboratory experiments (Hurle et al. 2013 ). In the laboratory, the interaction between a compound with protein is studied through spectroscopy approach such as UV-Vis absorption that involve chemical materials and chemical process (Suhartono et al. 2018) . Whereas the computational method is performed through modeling using chemical structure database, therefore, the research becomes more time saving and cost-efficient.
In this research, the fatty acids of Pliek U were analyzed by gas chromatography-mass spectrometry (GC-MS) and the potential drug activities of fatty acids to E-FABP were studied by reverse docking technique.
MATERIALS AND METHODS

SAMPLE EXTRACTION
Samples were purchased from Pliek U home industry in Matang Subdistrict, Bireuen District, Aceh Province. Pliek U was selected based on purposive sampling technique, with the criterium to be newly produced. Afterward, Pliek U was prepared to produce ethanolic Pliek U extract (EPUE) and ethanolic hexane residue Pliek U extract (EHRPUE).
As much as 250 g Pliek U was macerated with 1.5 L ethanol 96%. The mixture was put in a shaker at 130 rpm and 28°C for 48 h. It was filtered using vacuum filtration to obtain the macerate and residue. The obtained residue was re-extracted twice using separating funnel with 300 mL ethanol 96%. The filtrate was mixed with macerate and concentrated with rotary evaporator at 50°C. This procedure gives a result to ethanolic Pliek U extract (EPUE).
As much as 250 g Pliek U was macerated with 1.5 L n-hexane. The mixture was put in a shaker at 130 rpm and 28°C for 48 h. It was filtered using vacuum filtration to obtain the macerate and residue. The obtained residue was re-extracted twice using separating funnel with 300 mL n-hexane. The obtained residue was remacerated using separating funnel with 1.5 L ethanol 96%. All macerate and filtrate were mixed and concentrated with rotary evaporator at 50°C. This procedure gives a result to ethanolic hexane residue Pliek U extract (EHRPUE).
SAMPLE PREPARATION FOR GC-MS ANALYSIS
Samples were weighed 1 g (EPUE and EHRPUE). Four mL n-hexane p.a was added into each sample and vortexed for 2 min. The clear hexane extract was taken and transferred to the derivation tube, then dried with nitrogen bursts. Two mL of 2% NaOH (NaOH in methanol), sealed tightly and heated at 90°C for 5 min. After left to cool down, 2 mL of BF 3 in methanol, it was sealed tightly and reheated for 30 min. Then it was left until cold, before being extracted with 3 mL n-hexane p.a. The upper phase (n-hexane) was taken for GC-MS analysis.
GC-MS DATA ANALYSIS
The fatty acid compounds were analyzed by the peaks of the chromatogram based on MS data analysis. The area percentage (%) of each peak was used to determine the content percentage of fatty acid, which later was employed in the determination of predominant fatty acid within each sample.
PROCESS OF DOCKING
Prior to docking, the determination of the control compound, palmitic acid (C 16 H 32 O 2 ), is required. After that, the 3D structure of target compounds was downloaded from PubChem database, meanwhile the 3D structure of the protein is downloaded from the database of Protein Data Bank (GDP). Then, the natural ligand on target protein was cut using PyMOl application (https://pymol. en.softonic.com/?ex=DSK-1262.10). After all information were collected, the docking process between the control compound and prediction compound of the target protein using PyRx computer application (https://pyrx.sourceforge. io/downloads) was carried out.
VISUALIZATION OF DOCKING RESULT
Visualization of docking result was carried out by two software, namely PyMol and Discovery Studio (https:// www.3dsbiovia.com/products/collaborative-science/ biovia-discovery-studio/visualization-download.php).
RESULTS AND DISCUSSION
FATTY ACIDS ANALYSIS OF PLIEK U BY GC-MS GC-MS analysis showed that the predominant fatty acid content in both ethanolic extract (EPU) and ethanolic residual hexane (ERHPUE) extract was similar. Each sample had a different percentage of fatty acids (Table 1) . Lauric acid was the highest fatty acid contained in samples (EPUE = 35, 68% and ERHPUE = 29.70%), and followed by myristic acid (EPUE = 21.48% and ERHPUE = 25.06%), palmitic acid (EPUE = 13.72% and ERHPUE = 16.04%), oleic acid (EPUE = 11.98% and ERHPUE = 10.40%), stearic acid (EPUE = 5.17% and ERHPUE = 4.42%), capric acid (EPUE = 4.02% and ERHPUE = 4.94%), linoleic acid (EPUE = 3.68% and ERHPUE = 2.07%), and caprylic acid (EPUE = 3.32% and ERHPUE = 3.84%). Other fatty acid contents were detected less than 1%.
Based on GC-MS data, the predominant fatty acid contents in Pliek U was similar to the predominant fatty acid contents in coconut oil. The fatty acid contents in coconut oil were also dominated by lauric acid, mirystic acid and caprylic acid (Orsavova et al. 2015; Lin et al. 2018) . Therefore, Pliek U had the potential to be used for medical purposes, especially as a medical resource in drug therapy to treat atopic dermatitis.
MOLECULAR DOCKING STUDY BASED ON BINDING AFFINITY VALUE
Molecular docking was performed using the 3D structure of the target E-FABP protein with ligands (caprylic acid, capric acid, lauric acid, linoleic acid, myristic acid, and oleic acid) and a control ligand (palmitic acid). The results of common virtual docking using PyRx software is the affinity binding value of each ligand presented in Table 2 .
The binding affinity between palmitic acid (control ligand) and E-FABP was -5.8 Kcal/mol. Based on the binding affinity between ligand and E-FABP, only linoleic acid had a lower binding affinity compared to the control ligand (-5.9 Kcal/mol). The binding affinity value is important to identify the molecular and macromolecular interaction because it is the first role to facilitate the discovery and development of new drugs (Cournia et al. 2017; Du et al. 2016; Rufaidah et al. 2017) . The low binding affinity allows linoleic acid to have the great potential to bind E-FABP (target protein) with less energy, whereas it was not found in other fatty acids.
Gibbs energy theory states that the smaller the energy generated from a bond between the ligand and its receptor, the more stable the bond is. Therefore, the low binding affinity increases the stability of interaction between fatty acid and E-FABP (Lukitaningsih et al. 2015) . The research on mice that did not have E-FABP, as reported by Ogawa et al. (2011) , showed a reduction of linoleic acid compared to other fatty acids. This ascribes that linoleic acid is the main fatty acid that interacts with E-FABP.
VISUALIZATION OF INTERACTION BETWEEN FATTY ACID AND E-FABP
Using pyMOL software, interactions between predicted ligand (fatty acids) and target protein (E-FABP) were visualized side by side. The interactions were compared to the interaction between control ligand (palmitic acid) and E-FABP. The best interaction was justified based on the similarity of interaction between predicted ligand and E-FABP with control ligand and E-FABP. It was known that palmitic acid bound to E-FABP on amino acid residues of TYR A22, ARG A81, GLN A98, and LYS A61. The interaction visualizations of each ligand to E-FABP were described as follows:
Visualization of the interaction between Capric acid and E-FABP
The visualization of capric acid and E-FABP interaction (Figure 1) showed the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in the amino acid of ARG A81, while hydrophobic interactions occurred in amino acids of MET A23 and PHE A19. It can be concluded that the capric acid and palmitic acid bounded the same sides of E-FABP on amino acid ofARG A81.
Visualization of the interaction between Lauric acid and E-FABP
The visualization of lauric acid and E-FABP interaction (Figure 3) showed the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in amino acids of TYR A22, and GLN A98, meanwhile the hydrophobic interactions occurred in amino acids of ALA A78 and PHE A19. It can be concluded that lauric acid and palmitic acid bounded the same sides of E-FABP on amino acids of TYR A22 and GLN A98. 
Visualization of the interaction between Caprylic acid and E-FABP
The visualization of caprylic acid and E-FABP interaction (Figure 2) showed the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in amino acids of GLN A98, ARG A81, and TYR A22, meanwhile the hydrophobic interaction occurred in amino acids of TYR A131, ARG A129 and VAL A118. It can be concluded that caprylic acid and palmitic acid bounded the same sides of E-FABP on amino acids of GLN A98, ARG A81, and TYR A22. 
Visualization of the interaction between Myristic acid and E-FABP
The visualization of myristic acid and E-FABP interaction (Figure 4) indicated the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in the amino acids of THR A56 and ARG A809, while hydrophobic interactions occurred in the amino acids of MET A23 and PHE A19. It can be concluded that myristic acid and palmitic acid did not bind E-FABP to any same side. 
Visualization of the interaction between Oleic acid and E-FABP
The visualization of oleic acid and E-FABP ( Figure 5 ) interaction indicated the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in the amino acid of TYR A56, and hydrophobic interactions occurred in the amino acids of MET A23, LEU A56, and PHE A19. It can be concluded that oleic acid and palmitic acid did not bind E-FABP to any same side.
Visualization of the interaction between Linoleic acid and E-FABP
The visualization of linoleic acid and E-FABP interaction ( Figure 6 ) showed the presence of hydrogen bonds and hydrophobic interactions. Hydrogen bonds occurred in the amino acids of TYR A22, ARG A81, and GLN A98, while hydrophobic interactions occurred in the amino acids of PRO A41, LYS A61, and ALA A39. It can be concluded that linoleic acid and palmitic acid bounded the same sides of E-FABP on amino acids of GLN A98, ARG A81, TYR A22, and LYS A61.
to stratum corneum where filaggrin, the drug target, was located. Linoleic acid content in both EPUE and EHRPUE extracts showed that Pliek U had a great potential to be used as a drug resource and natural active ingredient for atopic dermatitis cream therapy. This result was also in line with the research, reported by Ogawa et al. (2011) , that E-FABP deletion resulted in a decrease of cellular linoleic acid, followed by a decrease of linoleic acid derivative, 13-hydroxyoctadecadienoic acid (13-HODE), the major metabolite of linoleic acid in the skin. Whereas, arachidonic and linolenic acids content remained unchanged suggesting that E-FABP and linoleic acid bound each other with higher affinity in keratinocytes (Ogawa et al. 2011 ). Furthermore, E-FABP induces keratinocyte differentiation and enhances the transcriptional activity of peroxisome proliferator-activated receptors (PPARs) by directly targeting fatty acid to PPARß (Owada et al. 2002) .
CONCLUSION
Pliek U extracts had been successfully analyzed by GC MS. The analysis result showed that lauric, myristic, palmitic, and oleic acids were predominant and followed by stearic, capric, linoleic, and caprylic acids. Based on molecular docking analysis, linoleic acid showed stable interaction and the best orientation of interaction to interact with E-FABP. Therefore, linoleic acid had the best potential as a drug candidate for atopic dermatitis treatment. Visualization of the interactions between all predicted ligands (fatty acids) and protein target (E-FABP) showed that myristic and oleic acids did not have any same side bound to E-FABP. Capric, caprylic and lauric acids had some same sides bound to E-FABP. Especially for linoleic acid, it had all the same sides bound to E-FABP. Based on this result, it can be concluded that linoleic acid had the best structural conformation to bind E-FABP with the best orientation of interaction.
According to the molecular docking analysis, both binding affinity and orientation of interaction, linoleic acid had the best potential to be a drug candidate in atopic dermatitis treatment. These fatty acids showed stable interaction and the best orientation of interaction to interact with E-FABP. Hence, linoleic acid can efficiently transport
